Literature DB >> 34337381

Investigation and management of an outbreak of COVID-19 infection in an acute admission unit in a District General Hospital: lessons learnt.

Chiranthi Iresha Kannangara1, Prema Seetulsingh1, Jiovanna Foley1, Glynis Bennett1, Tracey Carter1.   

Abstract

BACKGROUND: SARS-CoV-2 outbreaks are difficult to recognise and control due to its high infectivity and the wide range of clinical manifestations of the infection. An outbreak at Watford general hospital provided an opportunity to recognise the complexity involved in a COVID-19 outbreak investigation.
METHODS: An outbreak control team (OCT) was convened. The terms outbreak, a case and a significant exposure were defined as per Public Health England (PHE) Guidance and in the context of the local outbreak. Root cause analyses (RCAs) were carried out on cases to identify possible causes, possible route of transmission and any learning points. All contact patients and staff were screened with RT PCR and genomic sequencing was performed on a set of positive specimens.In addition to active contact tracing, screening and cohorting of patients and staff, standard and transmission-based precautions were reinforced to control the outbreak.
FINDINGS: Fifteen patients and four staff members were identified in this outbreak investigation. With contact tracing, screening and through strict infection control measures the outbreak was brought under control.
CONCLUSION: We could successfully contain the spread of this outbreak following PHE outbreak control guidelines and our local guidelines. We recognised several challenges in investigating a COVID-19 outbreak in a hospital setting. Problems arising from variable sensitivity of the tests, difficulty in differentiating COVID-19 related symptoms from underlying diseases, problems related to establishing the route of transmission, issues with contact tracing are discussed. Additionally, the importance and limitations of genomic studies in COVID-19 are discussed.
© 2021 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.

Entities:  

Keywords:  COVID 19; Infection control; Isolation; Outbreak; PCR; Screening

Year:  2021        PMID: 34337381      PMCID: PMC8312091          DOI: 10.1016/j.infpip.2021.100156

Source DB:  PubMed          Journal:  Infect Prev Pract        ISSN: 2590-0889


Introduction

World Health Organization declared COVID-19 as a “public-health emergency of international concern” on 30 January 2020. As of 1st June 2020, there were 6 million cases and 371166 deaths reported globally. [1]. Rapid detection, and suppression of local (community and healthcare associated) outbreaks is important to prevent wider spread of infection. In principle there are three types of measures to prevent an infectious epidemic: controlling the source of infection, breaking the cycle of transmission, and protecting the susceptible populations. With COVID-19, transmission is primarily through droplets, indirect transmission via contact with environmental surfaces and, also thought to be airborne. Isolation of patients with suspected disease, early detection, appropriate use of personal protective equipment (PPE), contact tracing and environmental decontamination, are important in preventing outbreaks in health care facilities. Despite these precautions a significant number of patients have acquired COVID-19 in healthcare settings. [2,3] Here we report the investigation and management of an outbreak in an acute admission unit in a District General Hospital.

Background

Watford General Hospital is a 521-bed acute district General Hospital situated in West Hertfordshire. After the first wave of COVID-19 (2020), the hospital commenced its routine activity in May. All acute admissions were screened for COVID-19 by a PCR test on day zero and day five-seven. Patients undergoing elective procedures were screened three days prior to their admission. [4]. The outbreak happened in a 60-bed acute admission ward (ward X in this article). This ward is divided into four zones (coded Zone X1, X2, X3 and X4). (Figure 1).
Figure 1

Basic floor plan of the ward X.

Basic floor plan of the ward X. Zone X1 and X2 are used to admit patients under cardiac and respiratory teams and received patients from other wards. Zone X3 and X4 are holding bays when the capacity in the acute admission unit for emergency patients is exceeded. Current PHE guidance on reducing the risk of transmission of COVID-19 in the hospital setting is followed in this unit. [5] There was no concurrent outbreak of COVID-19 in the hospital.

Methods

Description of the outbreak

Patient X1A was admitted to X1 zone with clinical and radiological evidence of pneumonia. His PCR for SARS -CoV-2 was negative on admission and on day 2 but became positive on day 9. He was considered as a “hospital-onset probable healthcare-associated infection” (first positive specimen date 8–14 days after admission) according to the PHE definitions. Patient required non-invasive ventilation and continued to deteriorate. A cohort, contact tracing and screening exercise was undertaken which resulted in the recognition of the outbreak. Our paper describes 15 patients who were identified during outbreak period from mid-June to early July 2020, three of whom were symptomatic, and the rest identified on screening (Table I).
Table I

Outbreak patient characteristics and outcome

Outbreak patient characteristics and outcome The objectives of this investigation were, firstly, to understand the extent of the spread of SARS-CoV-2 in our healthcare facility and secondly, to conduct a root cause analysis to identify lapses in current infection control practices.

Initial response

Considering the nature and the number of exposures to the “index patient” and as more patients were positive in the same unit during a 3-day period (Day -3 to Day 0) an outbreak was declared in mid-June 2020 (Day 0) as per PHE definition. [6] An Outbreak control team was convened.

Outbreak control team (OCT)

The OCT consisted of the Head of Microbiology department, also Infection Control Doctor, Director Infection Prevention and Control (also an executive Director), Microbiology consultants, operational manager, head of emergency planning, matron (medicine), deputy head of nursing (medicine), Infection Prevention and Control (IPC) personal assistant, IPC senior nurse, head of IPC Clinical Commissioning Group (CCG), senior Health Protection Practitioners from PHE, members of the Serious Incident Team and consultants from cardiology and respiratory medicine.

Outbreak investigation

Definitions

The first step was to agree on the definitions for an outbreak, a case, and significant exposure. Public Health England defines an outbreak as “two or more confirmed cases of COVID-19 or clinically suspected cases of COVID-19 among individuals associated with a specific setting with onset dates 8–14 days after admission within the same ward or wing of a hospital”. A significant exposure is defined as an Individual who has had close face-to-face contact with a COVID-19 patient within 2 metres for more than 15 minutes. A Health care worker providing direct care for a COVID-19 case, without recommended personal protective equipment (PPE) or with a possible breach of PPE is also considered a significant exposure. [7]. A case was defined as an individual (patient or staff) who stayed or worked in ward X from Day-3 until outbreak is declared over and have developed symptoms and radiological findings compatible with COVID-19 in the presence of a positive PCR test result.

Epidemiological method

We collected and analysed data from root cause analyses (RCAs) carried out on all 15 patients (such as patient movement and illness timeline (Figure 2). All staff members who had significant exposure were identified, contacted, and screened.
Figure 2

Timeline of patient movement and diagnosis. ∗The date in which outbreak was declared is taken as Day 0. ∗∗ Patients are coded according to the zone they were admitted and in the order they were recognized as part of the outbreak. ∗∗∗X4-A patient was first admitted and treated in hospital on day -65 to day -3. He was COVID +ve on Day-30 and was COVID -ve on Day-17. Pt was readmitted with loose stools and fever on Day-0 and was PCR +ve again on admission. He had repeat +ve test on Day 19. All patients had admission and day 7 COVID-PCR as part of routine practice. Admission screening PCR were negative in all patients except in X4A.

Timeline of patient movement and diagnosis. ∗The date in which outbreak was declared is taken as Day 0. ∗∗ Patients are coded according to the zone they were admitted and in the order they were recognized as part of the outbreak. ∗∗∗X4-A patient was first admitted and treated in hospital on day -65 to day -3. He was COVID +ve on Day-30 and was COVID -ve on Day-17. Pt was readmitted with loose stools and fever on Day-0 and was PCR +ve again on admission. He had repeat +ve test on Day 19. All patients had admission and day 7 COVID-PCR as part of routine practice. Admission screening PCR were negative in all patients except in X4A.

Laboratory method

All patients in ward X were screened, and tested by PCR.

PCR testing of samples

Nose, throat, and nasopharyngeal swabs were tested by the Cepheid, ePlex and SAMBA II commercial PCR assays or sent to the Source Bioscience lab in Nottingham. Cepheid GeneXpert assay is an automated multiplex real-time, reverse transcriptase polymerase chain reaction (RT-PCR) assay intended for the qualitative detection of SARS CoV-2. The procedure includes sample preparation, nucleic acid extraction, amplification and detection of the target sequence by real-time PCR. The ePlex Panel is an automated qualitative nucleic acid multiplex diagnostic test, which automates all aspects of nucleic acid testing including extraction, amplification, and detection. The SAMBA II instrument system is an automated system. The SAMBA II Assay Module performs sample extraction for nucleic acid amplification and detection.

Genomic sequencing

Available specimens were transferred to the Clinical Microbiology and Public Health Laboratory (CMPHL) in Cambridge for whole genomic sequencing. The primary samples received at the CMPHL were extracted and tested for SARS-CoV-2 by a validated in-house RT-qPCR assay. [8] Samples that passed an amplicon yield threshold (>5ng/ul) were sequenced by Nanopore. Sequencing took place in the Division of Virology, Department of Pathology at the University of Cambridge via Nanopore technology, following the ARTIC version 2 protocol with version 3 primer set. [[8], [9], [10]] The genomes were aligned using MAFFT v7.467 with default settings and SNP differences were defined from the alignment using the snp-dists package v 0.7.0. [11,12].

Environmental screening and interventions

It was decided not to undertake environmental sampling as the outbreak appeared to be controllable at the initial stage. However, environmental screening would be carried out if measures implemented failed to control the outbreak and if an environmental source was suspected.

Assessment and strengthening of standard precautions and transmission based precautions

Audits

Ward X nursing staff and infection control team carried out hand hygiene and Code of Practice (COP) audits. The COP Audit (based and adapted from the Health and Social Care Act 2008 code of practice) included general cleaning, cleaning of equipment and the environment, hand hygiene and PPE compliance.

Equipment and environment decontamination

This included enhanced cleaning in addition to the routine cleaning of frequently touched surfaces (bed tables, bed rails, arms of chairs, sinks, call bells and door handles) by increasing the frequency of cleaning (2–3 times per day) between patients and on every shift using a chlorine containing solution. Responsibilities of staff members in cleaning of the phones, workstations, computers, and other equipment were re-iterated.

Infection control interventions

Patient movement and placement

Ward X was closed for admissions for 28 days from declaration of the outbreak and remaining patients were kept under review. Two symptomatic patients were managed in isolation rooms and the remaining positive patients were cohorted in Zones and monitored. Privacy curtains were placed between the beds to minimise contact and further transmission. Discharged patient contacts were advised to self-isolate for 14 days.

Staff cohorting

To restrict the staff cross over, separate staff teams were assigned to each area.

Staff screening

Staff members who had significant exposure were swabbed and advised to self-isolate for 14 days from the exposure. All other staff members who worked in the unit (doctors, nurses, physiotherapists, phlebotomists, ward clerks and the housekeeping staff) were screened but allowed to continue to work pending the swab results.

Awareness of appropriate personal protective equipment (PPE)

PPE training was undertaken across the floor. Majority of staff were found to have already undergone training, but refresher training was completed according to the updated PPE recommendation of NHS England. [13]. Visitors: No visitors were allowed as per National Guidance.

Ventilation requirements

The design for this ward (X 1–4) building ventilation is based on the “mixed mode” model. This means that instead of fulfilling the six air changes per hour requirement (6 ACH) for a general inpatient ward via mechanical ventilation alone, the availability of natural ventilation is assessed at design stage and is then used to theoretically make up the difference. For instance, the design flows for this ward would only achieve 2 ACH which leaves the remaining 4 ACH to be made up by natural ventilation.

Results

Outbreak patient assessment

Following recognition of the first three patients, 43 contact patients were screened with PCR assays which identified 12 further infected patients. The 15 patients identified in this outbreak investigation were in 4 different zones (X1-3 patients, X2- 6 patients, X3-5 patients and X4- 1patient). Mean age of the patients was 78 years. The characteristics of the patients are summarized in Table I. Individual case assessments revealed several factors (multiple comorbidities in 14 out of 15 patients and advanced age) that may have contributed to the increased vulnerability and the outbreak situation.

Genomic sequencing

Fourteen specimens belonging to 13 patients were available for genomic sequencing. This comprised 8 primary samples and 6 RNA extract samples. Six out of fourteen samples passed an amplicon yield threshold (>5ng/ul) and were sequenced by Nanopore. The low pass rate is likely due to RNA degradation between sampling, extraction and sequencing which happened over a month after the samples were collected. Those six samples were from five patients. All six samples passed quality control filtering (>90% coverage). Four of those six specimens had the same genomic sequencing profiles and were from three patients from unit X2 and one patient from unit X 1 consistent with transmission of the same viral lineages either directly or within one or two intermediate hosts, between units X1 and X2. The remaining two samples were from one patient on unit X3 and had a distinct sequencing profile indicating that direct transmission was unlikely to have occurred from X1 or X2 to X3.

Staff screening

Nineteen staff members (five doctors and 14 nurses) who had contact with the index symptomatic patient were classified as high-risk exposure and they were swabbed and advised to self-isolate for 14 days after the last exposure. A further 141 staff members (permanent staff in unit and visiting staff) were screened and four were identified as positive by PCR and were asymptomatic; they were advised to self-isolate for seven days from the date of the test as this was the PHE guidance at the time. If they developed any symptoms during their self-isolation, they were advised to self-isolate for a further 7 days from the date of onset of their symptoms in line with the PHE guidance at the time (which was revised later).

Results of audits

Hand hygiene audit revealed 100% compliance for doctors and nurses and 93% compliance was noted for the Code of Practice audit.

End of outbreak

The interventions implemented from mid-June to end of June led to a decline in the number of cases detected and no new cases were identified during the following 28 days after first week of July. The outbreak investigation was officially brought to closure on the fourth week of July.

Discussion

Our actions were in accordance with the PHE guidelines on outbreak management. [14,15] This outbreak investigation and management met with several key challenges. Firstly, differentiating nosocomial cases from community acquired infections is difficult. The uncertainty is mainly fuelled by the variable sensitivity of the currently available test. Currently different studies have given different sensitivities for the PCR tests. According to one study the sensitivity of RT-PCR was lowest in pharyngeal swabs (32%) followed by nasal swabs (63%), while bronchoalveolar lavage has the highest sensitivity of 93%. [16] Overall sensitivity of the test has been suggested to be between 71% to 98%, and one systematic review reported that up to 54% of COVID-19 patients may have an initial false-negative RT-PCR. [17,18]. Patients identified in this outbreak had initial negative PCR and a subsequent positive test. Of these 15 patients there were a total of 28 initial negative PCR tests. Of these, 21 (75 %) were nasal and throat swabs. On this background we cannot rule out the possibility that some of the patients may have had or acquired the infection in the community and incubating it at the time they were admitted. In addition, X4-A was positive on admission. However, he was again positive on day 19. The patient had multiple comorbidities and was immunocompromised. It was difficult to determine whether X4-A is a persistent viral shedder or got reinfected during the outbreak, hence he was included in the outbreak investigation. The other possibility is persistence of viral RNA from the previous initial episode of infection in which case the patient may not have had ongoing infection and unlikely to be infectious. Secondly, there were difficulties in determining the exact time of acquisition of infection, hence in the detection of hospital acquired cases due to an overlap and similarity of symptoms with some of the patients' underlying cardiac or non-infective respiratory clinical condition and COVID 19 related symptoms. Some cases had shortness of breath, but detailed clinical evaluation pointed to the possible cardiac origin for their symptoms though it could also have been attributed to COVID-19. This overlap in symptomatology is also described with influenza in elderly patients who may instead present with a worsening of their underlying condition such as chronic obstructive pulmonary disease or congestive cardiac failure [19]. It was also challenging to establish a possible route of spread with a degree of certainty. Although patient X1-A was considered to be the index case in the outbreak (as X1-A was symptomatic and was on non-invasive ventilation and required more direct care resulting in multiple contacts), the first patient to be positive in this cluster was X2-E who did not have respiratory symptoms during admission. There was no patient link to explain direct transmission from X1-A in unit X1 to the X2 or X3 clusters or the case on X4. On the other hand, if we consider X2-E as the initial source, transmission to the X3 unit can be explained through X3-E though we still cannot determine a patient link to zones X1 and X4. Another possible explanation of the route of transmission is through staff working across the various areas or through contact with patients who were not initially detected due to a false negative PCR result but could still have been potentially infectious. This difficulty in identifying the source of infection is also documented in influenza outbreaks where routes of transmission are difficult to track and describe with precision limiting better understanding of disease dynamics. [20]. Thirdly, contact tracing also had potential issues. Due to the social and financial impact of being identified as a high-risk exposure and need for mandatory isolation for 14 days from the last exposure, there is a possibility for contacts to not volunteer for screening. As a result, we screened the entire staff who worked in the unit during the period of the outbreak. Furthermore, at the time of the outbreak our standard operating procedures on SARS-CoV-2 specimens did not specify post testing storage of samples for future genomic analysis. As a result, we were only able to send specimens on 13 patients. Through genomic analysis we were able to establish that the same viral lineage was possibly spreading in zones X1 and X2 but not X3 indicating a possible mixed outbreak. However, we could not establish the link to unit X4 through genomic analysis as the RNA had degraded in the specimen. However, based on the facts that the X4-A had been previously and persistently positive and had been in a side-room during their entire stay, the lack of further cases being identified on unit X-4 and the location of this unit (Figure 1), it would indicate that the case on X-4 may be a separate and unrelated occurrence to the outbreak further supporting the mixed picture. Genomic studies were not performed on specimens from staff members due to unavailability of specimens and this was a caveat in establishing the other possible route of transmission between units. In addition, due to lack of diversity of the whole genomic profile, the genomic linkage data established through this analysis needs to be viewed in the epidemiological context. Due to the infectious nature of SARS-CoV-2 and contribution of asymptomatic staff carriers to outbreaks described elsewhere the number of staff identified as possible contacts was high [21] though the number identified as positive was proportionately low (four staff) which can also lead to impact on the workforce and challenges in continuation of care. Regarding environmental aspects, the lay out of the ward X consisted of 6 bedded bays with shared bathroom facilities and only a limited set of side rooms which lends itself to more patient movement and more potential for transmission to occur. With regards to ventilation, we know that it is not practical to keep windows open all year round so there may well be instances when the remaining 4 air changes per hour (ACH) cannot be made up by natural ventilation on that ward to achieve compliance all year round. This is particularly relevant as there is now more evidence in support of air borne transmission of SARS-CoV-2 and the requirement for optimal ventilation.

Limitations

We were able to perform whole genome sequencing of six samples from five patients only. This may have been due to the degradation of RNA as a result of delay in analysis. Furthermore, staff samples that tested positive were also not available for genomic sequencing as they were processed in an off-site lab. It is also important to recognise the role of genomic sequencing in this situation. Sequencing is a useful tool to “rule-out direct transmission” if there are significant differences. However, if the genomes are identical, it gives a clue of the possibility of transmission either directly or within 1 or 2 intermediate hosts, but it does not prove transmission.

Conclusion

We could successfully contain the spread of this outbreak following PHE outbreak control guidelines and our local guidelines. We recognised several challenges in the investigation of a COVID-19 outbreak, including the sensitivity of the PCR assay, the limited understanding of the transmission dynamics, time of acquisition of the infection, the number of confounding factors (such as overlapping clinical features between COVID 19 and other respiratory and cardiac conditions), the role of staff as asymptomatic carriers all adding to a layer of complexity in the final interpretation of data. Introduction of lateral flow antigen testing for routine screening of asymptomatic staff will identify positive staff at an early stage and will limit transmission and the role of health care workers in outbreaks in the future [22] as will vaccination of both health care workers and patients. Early recognition, prompt interventions and good communication were the key points in controlling this outbreak. We believe that this is the first report of the investigation and management of a COVID 19 outbreak in the UK highlighting the key messages above.

Ethical approval

This is a report of an investigation that was conducted as a routine procedure following an outbreak and no ethical approval was sought prior to the investigation. Informed consent was not gained from patients involved in this outbreak. All patients were treated according to clinical judgement and infection control practices in order to treat them and control the outbreak according to local guidelines. Patients did not undergo randomisation or intervention for the purpose of this report. Data has been analysed and presented anonymously.
  8 in total

1.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  Interpreting a covid-19 test result.

Authors:  Jessica Watson; Penny F Whiting; John E Brush
Journal:  BMJ       Date:  2020-05-12

3.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

4.  Hospital-acquired influenza: a synthesis using the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement.

Authors:  N Voirin; B Barret; M-H Metzger; P Vanhems
Journal:  J Hosp Infect       Date:  2008-10-25       Impact factor: 3.926

5.  Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China.

Authors:  Xiaorong Wang; Qiong Zhou; Yukun He; Lingbo Liu; Xinqian Ma; Xiaoshan Wei; Nanchuan Jiang; Limei Liang; Yali Zheng; Ling Ma; Yu Xu; Dong Yang; Jianchu Zhang; Bohan Yang; Ning Jiang; Tao Deng; Bingbing Zhai; Yang Gao; Wenxuan Liu; Xinghua Bai; Tao Pan; Guoqing Wang; Yujun Chang; Zhi Zhang; Huanzhong Shi; Wan-Li Ma; Zhancheng Gao
Journal:  Eur Respir J       Date:  2020-06-04       Impact factor: 16.671

6.  Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong.

Authors:  S C Y Wong; R T-S Kwong; T C Wu; J W M Chan; M Y Chu; S Y Lee; H Y Wong; D C Lung
Journal:  J Hosp Infect       Date:  2020-04-04       Impact factor: 3.926

7.  Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.

Authors:  Lucy Rivett; Sushmita Sridhar; Dominic Sparkes; Matthew Routledge; Nick K Jones; Ian G Goodfellow; Stephen Baker; Michael P Weekes; Sally Forrest; Jamie Young; Joana Pereira-Dias; William L Hamilton; Mark Ferris; M Estee Torok; Luke Meredith; Martin D Curran; Stewart Fuller; Afzal Chaudhry; Ashley Shaw; Richard J Samworth; John R Bradley; Gordon Dougan; Kenneth Gc Smith; Paul J Lehner; Nicholas J Matheson; Giles Wright
Journal:  Elife       Date:  2020-05-11       Impact factor: 8.140

8.  Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.

Authors:  Luke W Meredith; William L Hamilton; Ben Warne; Charlotte J Houldcroft; Myra Hosmillo; Aminu S Jahun; Martin D Curran; Surendra Parmar; Laura G Caller; Sarah L Caddy; Fahad A Khokhar; Anna Yakovleva; Grant Hall; Theresa Feltwell; Sally Forrest; Sushmita Sridhar; Michael P Weekes; Stephen Baker; Nicholas Brown; Elinor Moore; Ashley Popay; Iain Roddick; Mark Reacher; Theodore Gouliouris; Sharon J Peacock; Gordon Dougan; M Estée Török; Ian Goodfellow
Journal:  Lancet Infect Dis       Date:  2020-07-14       Impact factor: 71.421

  8 in total
  2 in total

1.  Risk factors for nosocomial SARS-CoV-2 infections in patients: results from a retrospective matched case-control study in a tertiary care university center.

Authors:  Seven Johannes Sam Aghdassi; Frank Schwab; Luis Alberto Peña Diaz; Annika Brodzinski; Giovanni-Battista Fucini; Sonja Hansen; Britta Kohlmorgen; Brar Piening; Beate Schlosser; Sandra Schneider; Beate Weikert; Miriam Wiese-Posselt; Sebastian Wolff; Michael Behnke; Petra Gastmeier; Christine Geffers
Journal:  Antimicrob Resist Infect Control       Date:  2022-01-17       Impact factor: 4.887

2.  Outbreak caused by the SARS-CoV-2 Omicron variant in the psychiatric ward of a general hospital in Brazil.

Authors:  Tazio Vanni; Moema Silva Menezes; Letícia Olivier Sudbrack; Fabiana Futiwaki; Linda Stéphany Bezerra; Sergio Cabral Filho; Edinan Oliveira Neto; Paulo Giovanni Pinheiro Cortez; Fabiano José Queiroz Costa; Lucas Luiz Vieira; Mariana Matos Roll; Wildo Navegantes de Araújo; Maria Almiron; André Machado de Siqueira; Liliana Moscoso Ribeiro; Julival Fagundes Ribeiro
Journal:  Rev Soc Bras Med Trop       Date:  2022-08-05       Impact factor: 2.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.